IFNα activates dormant haematopoietic stem cells in vivo
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Maintenance of the blood system is dependent on dormant haematopoietic stem cells (HSCs) with long-term self-renewal capacity. After injury these cells are induced to proliferate to quickly re-establish homeostasis. The signalling molecules promoting the exit of HSCs out of the dormant stage remain largely unknown. Here we show that in response to treatment of mice with interferon-alpha (IFNalpha), HSCs efficiently exit G(0) and enter an active cell cycle. HSCs respond to IFNalpha treatment by the increased phosphorylation of STAT1 and PKB/Akt (also known as AKT1), the expression of IFNalpha target genes, and the upregulation of stem cell antigen-1 (Sca-1, also known as LY6A). HSCs lacking the IFNalpha/beta receptor (IFNAR), STAT1 (ref. 3) or Sca-1 (ref. 4) are insensitive to IFNalpha stimulation, demonstrating that STAT1 and Sca-1 mediate IFNalpha-induced HSC proliferation. Although dormant HSCs are resistant to the anti-proliferative chemotherapeutic agent 5-fluoro-uracil, HSCs pre-treated (primed) with IFNalpha and thus induced to proliferate are efficiently eliminated by 5-fluoro-uracil exposure in vivo. Conversely, HSCs chronically activated by IFNalpha are functionally compromised and are rapidly out-competed by non-activatable Ifnar(-/-) cells in competitive repopulation assays. Whereas chronic activation of the IFNalpha pathway in HSCs impairs their function, acute IFNalpha treatment promotes the proliferation of dormant HSCs in vivo. These data may help to clarify the so far unexplained clinical effects of IFNalpha on leukaemic cells, and raise the possibility for new applications of type I interferons to target cancer stem cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Chronic pro-inflammatory signaling due to chronic infections or repetitive sterile inflammation, however, has been shown to be detrimental to HSPC self-renewal, promoting loss of quiescence and differentiation [61–65].”
From Clonal hematopoiesis and inflammation – the perpetual cycle (2023) · cites this paper as [63]
In the citing paper
“The isolated effects of individual inflammatory cytokines, including type 1 interferons (IFNa/b) 1-3 , type 2 IFN (IFNg) 4-6 , TNFa 7,8 , and IL-1 9-11 , have been well-documented in mouse hematopoietic development.”
From Type 1 interferon perturbates clonal competition by reshaping human blood development (2026) · cites this paper as [9]
In the citing paper
“multiple different sterile and infection-associated inflammatory stimuli have been shown to provoke primitive hematopoietic stem cells (HSCs) to exit their long-term quiescent state and enter into active proliferation”
From Inflammatory exposure drives long-lived impairment of hematopoietic stem cell self-renewal activity and accelerated aging (2022) · cites this paper as Essers et al., 2009
In the citing paper
“The sterile inflammation that it promotes results in a temporarily discrete hematologic response consisting of transient peripheral blood (PB) cytopenias and a parallel increase in proliferation of long-term HSCs (LT-HSCs), all of which return to homeostatic levels within 4 days”
From Inflammatory exposure drives long-lived impairment of hematopoietic stem cell self-renewal activity and accelerated aging (2022) · cites this paper as Essers et al., 2009
In the citing paper
“In addition to IL-6, other cytokines such as IFNα, IFNγ, IL-1α, IL-1β, and TNFα can also directly activate HSCs (Baldridge et al., 2010; Essers et al., 2009; Pietras et al., 2014; Pietras et al., 2016; Sujer, 2014).”
From Inhibition of Inflammatory Signaling in Tet2 Mutant Preleukemic Cells Mitigates Stress-Induced Abnormalities and Clonal Hematopoiesis (2018) · cites this paper as Essers et al., 2009
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Darnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080
HOW CELLS RESPOND TO INTERFERONS
Stark, G. R., Kerr, I. M., Williams, B. R. G., Silverman, R. H., & Schreiber, R. D. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.227 · Cited by 3,932
Kiel, M. J., Yilmaz, Ö. H., Iwashita, T., Yilmaz, O. H., Terhorst, C., & Morrison, S. J. (2005) · Cell · doi:10.1016/j.cell.2005.05.026 · Cited by 3,168
Functional Role of Type I and Type II Interferons in Antiviral Defense
Müller, U., Steinhoff, U., Reis, L. F. L., Hemmi, S., Pavlovic, J., Zinkernagel, R. M., & Aguet, M. (1994) · Science · doi:10.1126/science.8009221 · Cited by 2,453
Long-Term Lymphohematopoietic Reconstitution by a Single CD34-Low/Negative Hematopoietic Stem Cell
Osawa, M., Hanada, K.-I., Hamada, H., & Nakauchi, H. (1996) · Science · doi:10.1126/science.273.5272.242 · Cited by 2,140
Wilson, A., Laurenti, E., Oser, G., van der Wath, R. C., Blanco-Bose, W., Jaworski, M., Offner, S., Dunant, C. F., Eshkind, L., Bockamp, E., et al. (2008) · Cell · doi:10.1016/j.cell.2008.10.048 · Cited by 1,908
Self-citationInducible Gene Targeting in Mice
Kühn, R., Schwenk, F., Aguet, M., & Rajewsky, K. (1995) · Science · doi:10.1126/science.7660125 · Cited by 1,641
Bone-marrow haematopoietic-stem-cell niches
Wilson, A., & Trumpp, A. (2006) · Nature Reviews Immunology · doi:10.1038/nri1779 · Cited by 1,354
Self-citationHematopoietic Stem Cell Quiescence Maintained by p21 cip1/waf1
Cheng, T., Rodrigues, N., Shen, H., Yang, Y.-G., Dombkowski, D., Sykes, M., & Scadden, D. T. (2000) · Science · doi:10.1126/science.287.5459.1804 · Cited by 1,339
Targeted Disruption of the Mouse Stat1 Gene Results in Compromised Innate Immunity to Viral Disease
Durbin, J. E., Hackenmiller, R., Simon, M. C., & Levy, D. E. (1996) · Cell · doi:10.1016/s0092-8674(00)81289-1 · Cited by 1,242
Cited by
Items 101–200 of 1,002
Myocardial Infarction Activates CCR2+ Hematopoietic Stem and Progenitor Cells
Dutta, P., Sager, H. B., Stengel, K. R., Naxerova, K., Courties, G., Saez, B., Silberstein, L., Heidt, T., Sebas, M., Sun, Y., et al. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2015.04.008 · Cited by 221
Roles of Nrf2 in cell proliferation and differentiation
Murakami, S., & Motohashi, H. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.06.030 · Cited by 225
The renaissance of interferon therapy for the treatment of myeloid malignancies
Kiladjian, J.-J., Mesa, R. A., & Hoffman, R. (2011) · Blood · doi:10.1182/blood-2010-08-258772 · Cited by 212
Borst, P. (2012) · Open Biology · doi:10.1098/rsob.120066 · Cited by 212
Impact of interferon-γ on hematopoiesis
de Bruin, A. M., Voermans, C., & Nolte, M. A. (2014) · Blood · doi:10.1182/blood-2014-04-568451 · Cited by 215
Interferon-γ impairs proliferation of hematopoietic stem cells in mice
de Bruin, A. M., Demirel, Ö., Hooibrink, B., Brandts, C. H., & Nolte, M. A. (2013) · Blood · doi:10.1182/blood-2012-05-432906 · Cited by 210
Balancing dormant and self-renewing hematopoietic stem cells
Wilson, A., Laurenti, E., & Trumpp, A. (2009) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2009.08.005 · Cited by 201
Self-citationSeo, S.-U., Kwon, H.-J., Ko, H.-J., Byun, Y.-H., Seong, B. L., Uematsu, S., Akira, S., & Kweon, M.-N. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1001304 · Cited by 211
“In accordance, one recent study showed that IFN-I signaling triggers hematopoietic stem cell (HSC) proliferation [14].”
Mirantes, C., Passegué, E., & Pietras, E. M. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.08.017 · Cited by 211
Cuartero, S., Weiss, F. D., Dharmalingam, G., Guo, Y., Ing-Simmons, E., Masella, S., Robles-Rebollo, I., Xiao, X., Wang, Y.-F., Barozzi, I., et al. (2018) · Nature Immunology · doi:10.1038/s41590-018-0184-1 · Cited by 210
Tesi, B., Davidsson, J., Voss, M., Rahikkala, E., Holmes, T. D., Chiang, S. C. C., Komulainen-Ebrahim, J., Gorcenco, S., Rundberg Nilsson, A., Ripperger, T., et al. (2017) · Blood · doi:10.1182/blood-2016-10-743302 · Cited by 207
OTULIN limits cell death and inflammation by deubiquitinating LUBAC
Heger, K., Wickliffe, K. E., Ndoja, A., Zhang, J., Murthy, A., Dugger, D. L., Maltzman, A., de Sousa e Melo, F., Hung, J., Zeng, Y., et al. (2018) · Nature · doi:10.1038/s41586-018-0256-2 · Cited by 199
Epigenetic Memory Underlies Cell-Autonomous Heterogeneous Behavior of Hematopoietic Stem Cells
Yu, V. W. C., Yusuf, R. Z., Oki, T., Wu, J., Saez, B., Wang, X., Cook, C., Baryawno, N., Ziller, M. J., Lee, E., et al. (2016) · Cell · doi:10.1016/j.cell.2016.10.045 · Cited by 200
Opposing Roles of Type I Interferons in Cancer Immunity
Boukhaled, G. M., Harding, S., & Brooks, D. G. (2021) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-031920-093932 · Cited by 191
Less Is More: Unveiling the Functional Core of Hematopoietic Stem Cells through Knockout Mice
Rossi, L., Lin, K. K., Boles, N. C., Yang, L., King, K. Y., Jeong, M., Mayle, A., & Goodell, M. A. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.08.006 · Cited by 194
“…work on Type 1 and Type II interferons (Ifns) has illuminated their central role in controlling HSCs, as they can drive dormant stem cells into an active and proliferative state by acting directly on the stem cells rather than by altering their niche (Baldridge et al., 2010; Essers et al., 2009).”
BackgroundCOVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects
Smadja, D. M., Mentzer, S. J., Fontenay, M., Laffan, M. A., Ackermann, M., Helms, J., Jonigk, D., Chocron, R., Pier, G. B., Gendron, N., et al. (2021) · Angiogenesis · doi:10.1007/s10456-021-09805-6 · Cited by 200
Fgd5 identifies hematopoietic stem cells in the murine bone marrow
Gazit, R., Mandal, P. K., Ebina, W., Ben-Zvi, A., Nombela-Arrieta, C., Silberstein, L. E., & Rossi, D. J. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20130428 · Cited by 198
“…acid (polyI:polyC) elicits a systemic interferon response that is known to activate and drive HSCs into cycle (Baldridge et al., 2010; Essers et al., 2009) potentially confounding interpretations using this strain, particularly in regard to HSC cell cycle status and regulation of…”
BackgroundMullally, A., Bruedigam, C., Poveromo, L., Heidel, F. H., Purdon, A., Vu, T., Austin, R., Heckl, D., Breyfogle, L. J., Kuhn, C. P., et al. (2013) · Blood · doi:10.1182/blood-2012-05-432989 · Cited by 189
“Consistent with previous reports, IFNa treatment caused activation of cell cycle in WT and Jak2 LT-HSCs.(27,28) Importantly, Jak2 LT-HSCs were more sensitive to IFNa treatment compared with WT LT-HSCs, as evidenced by significantly reduced quiescent, but more cycling LT-HSCs in Jak2 compared with WT cells after IFNa t…”
BackgroundMethodInfluentialCancer Stem Cells and Chemosensitivity
Maugeri-Saccà, M., Vigneri, P., & De Maria, R. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2538 · Cited by 201
Targeting leukemic stem cells by breaking their dormancy
Essers, M. A. G., & Trumpp, A. (2010) · Molecular Oncology · doi:10.1016/j.molonc.2010.06.001 · Cited by 188
“In contrast to the previous in vitro data, we have recently shownthat, treatmentofmicewith IFNa induces transientproliferation of progenitors and quiescent HSCs within hours of application of IFNa in vivo (Figure 2) (Essers et al., 2009).”
BackgroundResultInfluentialSelf-citationSize Does Matter: Why Polyploid Tumor Cells are Critical Drug Targets in the War on Cancer
Coward, J., & Harding, A. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00123 · Cited by 192
HIF1α is required for survival maintenance of chronic myeloid leukemia stem cells
Zhang, H., Li, H., Xi, H. S., & Li, S. (2012) · Blood · doi:10.1182/blood-2011-10-387381 · Cited by 191
Burberry, A., Zeng, M. Y., Ding, L., Wicks, I., Inohara, N., Morrison, S. J., & Núñez, G. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.05.004 · Cited by 191
“…intracellular signaling, or indirectly via production of inflammatory cytokines or alterations in the bone marrow niche (Baldridge et al., 2010; Chen et al., 2010; Esplin et al., 2011; Essers et al., 2009; Johns et al., 2009; Rodriguez et al., 2009; Scumpia et al., 2010; Takizawa et al., 2011).”
Perry, J. M., He, X. C., Sugimura, R., Grindley, J. C., Haug, J. S., Ding, S., & Li, L. (2011) · Genes & Development · doi:10.1101/gad.17421911 · Cited by 188
“Recent studies have shown that INF also increases phosphorylation of Akt (Essers et al. 2009).”
BackgroundADAR1 promotes malignant progenitor reprogramming in chronic myeloid leukemia
Jiang, Q., Crews, L. A., Barrett, C. L., Chun, H.-J., Court, A. C., Isquith, J. M., Zipeto, M. A., Goff, D. J., Minden, M., Sadarangani, A., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1213021110 · Cited by 190
Gnani, D., Crippa, S., della Volpe, L., Rossella, V., Conti, A., Lettera, E., Rivis, S., Ometti, M., Fraschini, G., Bernardo, M. E., et al. (2019) · Aging Cell · doi:10.1111/acel.12933 · Cited by 188
“In particular, it has been reported that chronic inflammation drives HSPC myeloid skewing and leads to HSPC exhaustion during aging (Essers et al., 2009; Haas et al., 2015; Pietras et al., 2016).”
BackgroundDistinct Clinical Phenotypes Associated with JAK2V617F Reflect Differential STAT1 Signaling
Chen, E., Beer, P. A., Godfrey, A. L., Ortmann, C. A., Li, J., Costa-Pereira, A. P., Ingle, C. E., Dermitzakis, E. T., Campbell, P. J., & Green, A. R. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.10.013 · Cited by 173
“Normal HSC function is regulated by basal IFN tone (Baldridge et al., 2010; Essers et al., 2009; Zhao et al., 2010) and increased IFNγ or IFNα signaling results in HSC exhaustion (Trumpp et al., 2010).”
BackgroundAblation of Fbxw7 Eliminates Leukemia-Initiating Cells by Preventing Quiescence
Takeishi, S., Matsumoto, A., Onoyama, I., Naka, K., Hirao, A., & Nakayama, K. I. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.01.026 · Cited by 178
“Given that gene ablation induced by pIpC is mediated by interferon, which has been shown to act directly on HSCs to induce cell cycle progression (Essers et al., 2009), recipients of control bone marrow cells as well as those of Mx1-Cre;Fbxw7F/F cells were injected with pIpC to eliminate any bias…”
MethodWhat does the concept of the stem cell niche really mean today?
Lander, A. D., Kimble, J., Clevers, H., Fuchs, E., Montarras, D., Buckingham, M., Calof, A. L., Trumpp, A., & Oskarsson, T. (2012) · BMC Biology · doi:10.1186/1741-7007-10-19 · Cited by 180
Self-citationJoseph, C., Quach, J. M., Walkley, C. R., Lane, S. W., Lo Celso, C., & Purton, L. E. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2013.10.010 · Cited by 181
Li, L., Krymskaya, L., Wang, J., Henley, J., Rao, A., Cao, L.-F., Tran, C.-A., Torres-Coronado, M., Gardner, A., Gonzalez, N., et al. (2013) · Molecular Therapy · doi:10.1038/mt.2013.65 · Cited by 181
Burchert, A., Müller, M. C., Kostrewa, P., Erben, P., Bostel, T., Liebler, S., Hehlmann, R., Neubauer, A., & Hochhaus, A. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.5075 · Cited by 174
Sashida, G., Harada, H., Matsui, H., Oshima, M., Yui, M., Harada, Y., Tanaka, S., Mochizuki-Kashio, M., Wang, C., Saraya, A., et al. (2014) · Nature Communications · doi:10.1038/ncomms5177 · Cited by 167
Type-I Interferon Responses: From Friend to Foe in the Battle against Chronic Viral Infection
Murira, A., & Lamarre, A. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00609 · Cited by 173
HSC Niche Biology and HSC Expansion Ex Vivo
Kumar, S., & Geiger, H. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.07.003 · Cited by 152
Hasan, S., Lacout, C., Marty, C., Cuingnet, M., Solary, E., Vainchenker, W., & Villeval, J.-L. (2013) · Blood · doi:10.1182/blood-2013-04-498956 · Cited by 156
Type I Interferons and Natural Killer Cell Regulation in Cancer
Müller, L., Aigner, P., & Stoiber, D. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00304 · Cited by 160
Host Immune Response to Infection and Cancer: Unexpected Commonalities
Goldszmid, R. S., Dzutsev, A., & Trinchieri, G. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.02.003 · Cited by 165
“Acute exposure to either type I interferons (IFNs) or IFN-g triggers activation and cycling of HSCs and, together with tumor necrosis factor (TNF), induces and skews the differentiation of monocytic lineages (Baldridge et al., 2011; de Bruin et al., 2012; Essers et al., 2009).”
Inflammatory signaling regulates hematopoietic stem and progenitor cell emergence in vertebrates
He, Q., Zhang, C., Wang, L., Zhang, P., Ma, D., Lv, J., & Liu, F. (2015) · Blood · doi:10.1182/blood-2014-09-601542 · Cited by 170
Role of Interleukin 6 in Innate Immunity to Mycobacterium tuberculosis Infection
Martinez, A. N., Mehra, S., & Kaushal, D. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit037 · Cited by 164
Stretching the limits: from homeostasis to stem cell plasticity in wound healing and cancer
Ge, Y., & Fuchs, E. (2018) · Nature Reviews Genetics · doi:10.1038/nrg.2018.9 · Cited by 168
Pascutti, M. F., Erkelens, M. N., & Nolte, M. A. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00364 · Cited by 166
Stem cell quiescence: the challenging path to activation
Urbán, N., & Cheung, T. H. (2021) · Development · doi:10.1242/dev.165084 · Cited by 183
“Although chronic interferon A (IFNA) is detrimental to HSCs, a short pulse can activate dormant LT-HSCs, promoting blood regeneration (Essers et al., 2009).”
BackgroundAntiproliferative Properties of Type I and Type II Interferon
Bekisz, J., Baron, S., Balinsky, C., Morrow, A., & Zoon, K. C. (2010) · Pharmaceuticals · doi:10.3390/ph3040994 · Cited by 150
“It has been proposed that this pre-treatment with IFN-α results in the CML stem cells becoming sensitized to Gleevec [122].”
BackgroundGene Therapy of Chronic Granulomatous Disease: The Engraftment Dilemma
Grez, M., Reichenbach, J., Schwäble, J., Seger, R., Dinauer, M. C., & Thrasher, A. J. (2011) · Molecular Therapy · doi:10.1038/mt.2010.232 · Cited by 162
Type I interferons: diversity of sources, production pathways and effects on immune responses
Swiecki, M. K., & Colonna, M. (2011) · Current Opinion in Virology · doi:10.1016/j.coviro.2011.10.026 · Cited by 187
Taniguchi Ishikawa, E., Gonzalez-Nieto, D., Ghiaur, G., Dunn, S. K., Ficker, A. M., Murali, B., Madhu, M., Gutstein, D. E., Fishman, G. I., Barrio, L. C., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120358109 · Cited by 157
Regulation of Hematopoietic Stem Cell Activity by Inflammation
Schuettpelz, L. G., & Link, D. C. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00204 · Cited by 158
Gammaretroviral Vectors: Biology, Technology and Application
Maetzig, T., Galla, M., Baum, C., & Schambach, A. (2011) · Viruses · doi:10.3390/v3060677 · Cited by 190
“Under steady state hematopoiesis, HSC cycle infrequently with extended periods of dormancy between cell divisions, which helps protecting their regenerative capacity [154–157].”
BackgroundRodriguez-Meira, A., Norfo, R., Wen, S., Chédeville, A. L., Rahman, H., O’Sullivan, J., Wang, G., Louka, E., Kretzschmar, W. W., Paterson, A., et al. (2023) · Nature Genetics · doi:10.1038/s41588-023-01480-1 · Cited by 158
Ca2+–mitochondria axis drives cell division in hematopoietic stem cells
Umemoto, T., Hashimoto, M., Matsumura, T., Nakamura-Ishizu, A., & Suda, T. (2018) · Journal of Experimental Medicine · doi:10.1084/jem.20180421 · Cited by 145
“HSCs exit quiescence and actively cycle upon interferon treatment or 5-fluoruracil (5-FU)–induced BM suppression (Harrison and Lerner, 1991; Essers et al., 2009; Baldridge et al., 2010).”
BackgroundMechanisms regulating dendritic cell specification and development
Watowich, S. S., & Liu, Y. (2010) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00949.x · Cited by 148
Majer, O., Bourgeois, C., Zwolanek, F., Lassnig, C., Kerjaschki, D., Mack, M., Müller, M., & Kuchler, K. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002811 · Cited by 156
“mice do not show this retention phenotype, most likely because IFN-I signaling might also affect the primary differentiation or proliferation of monocytes within the BM”
BackgroundThe role of cytokines in the initiation and progression of myelofibrosis
Hasselbalch, H. C. (2013) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2013.01.004 · Cited by 162
Global virus outbreaks: Interferons as 1st responders
Wang, B. X., & Fish, E. N. (2019) · Seminars in Immunology · doi:10.1016/j.smim.2019.101300 · Cited by 148
“At the earliest stages of leukocyte development, IFN-α signaling has been shown to affect the renewal and proliferation of hematopoietic stem cells (HSCs) [60, 61] .”
BackgroundInfluentialWhen dormancy fuels tumour relapse
Santos-de-Frutos, K., & Djouder, N. (2021) · Communications Biology · doi:10.1038/s42003-021-02257-0 · Cited by 165
Aging-associated inflammation promotes selection for adaptive oncogenic events in B cell progenitors
Henry, C. J., Casás-Selves, M., Kim, J., Zaberezhnyy, V., Aghili, L., Daniel, A. E., Jimenez, L., Azam, T., McNamee, E. N., Clambey, E. T., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci83024 · Cited by 148
C/EBPa controls acquisition and maintenance of adult haematopoietic stem cell quiescence
Ye, M., Zhang, H., Amabile, G., Yang, H., Staber, P. B., Zhang, P., Levantini, E., Alberich-Jordà, M., Zhang, J., Kawasaki, A., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2698 · Cited by 142
Re-emergence of interferon-α in the treatment of chronic myeloid leukemia
Talpaz, M., Hehlmann, R., Quintás-Cardama, A., Mercer, J., & Cortes, J. (2013) · Leukemia · doi:10.1038/leu.2012.313 · Cited by 137
Schuettpelz, L. G., Borgerding, J. N., Christopher, M. J., Gopalan, P. K., Romine, M. P., Herman, A. C., Woloszynek, J. R., Greenbaum, A. M., & Link, D. C. (2014) · Leukemia · doi:10.1038/leu.2014.68 · Cited by 138
Type-I-interferons in infection and cancer: Unanticipated dynamics with therapeutic implications
Musella, M., Manic, G., Maria, R. D., Vitale, I., & Sistigu, A. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1314424 · Cited by 157
Interferons in cancer immunoediting: sculpting metastasis and immunotherapy response
von Locquenghien, M., Rozalén, C., & Celià-Terrassa, T. (2021) · Journal of Clinical Investigation · doi:10.1172/jci143296 · Cited by 150
“Moreover, IFN-α mediates activation of quiescent hematopoietic stem cells in vivo (148) as well as prostate cancer cells in bone metastasis (111).”
BackgroundThe haematopoietic stem cell niche at a glance
Lo Celso, C., & Scadden, D. T. (2011) · Journal of Cell Science · doi:10.1242/jcs.074112 · Cited by 141
“An analysis of the response to interferon a (IFNa) treatment (which mimics activation of the immune response) was the first study that highlighted a clear function for Sca1 (stem cell antigen 1) (Essers et al., 2009), which has long been recognised as a marker of mouse HSPCs.”
Metabolism and the Control of Cell Fate Decisions and Stem Cell Renewal
Ito, K., & Ito, K. (2016) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-111315-125134 · Cited by 164
“Stress factors (e.g., infection or polyinosinicpolycytidylic acid, thrombopoietin, granulocyte-colony-stimulating factor, or chronic blood loss) also induce HSC cycling (Essers et al. 2009, Trumpp et al. 2010, Walter et al. 2015).”
MicroRNA-146a acts as a guardian of the quality and longevity of hematopoietic stem cells in mice
Zhao, J. L., Rao, D. S., O’Connell, R. M., Garcia-Flores, Y., & Baltimore, D. (2013) · eLife · doi:10.7554/elife.00537 · Cited by 135
Sánchez‐Aguilera, A., Arranz, L., Martín-Pérez, D., García‐García, A., Stavropoulou, V., Kubovčáková, L., Isern, J., Martín-Salamanca, S., Langa, X., Skoda, R. C., et al. (2014) · Cell stem cell · doi:10.1016/j.stem.2014.11.002 · Cited by 146
SIRT6 Controls Hematopoietic Stem Cell Homeostasis through Epigenetic Regulation of Wnt Signaling
Wang, H., Diao, D., Shi, Z., Zhu, X., Gao, Y., Gao, S., Liu, X., Wu, Y., Rudolph, K. L., Liu, G., et al. (2016) · Cell stem cell · doi:10.1016/j.stem.2016.03.005 · Cited by 142
Targeting innate immunity for tuberculosis vaccination
Khader, S. A., Divangahi, M., Hanekom, W. A., Hill, P. C., Maeurer, M. J., Makar, K. W., Mayer-Barber, K. D., Mhlanga, M. M., Nemes, E., Schlesinger, L. S., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci128877 · Cited by 145
“org Volume 129 Number 9 September 2019 and type II IFN (IFN-γ) can increase HSC proliferation (81, 84, 86, 97), but they have opposing effects in the killing of Mtb by macrophages (98, 99).”
BackgroundMapperley, C., van de Lagemaat, L. N., Lawson, H., Tavosanis, A., Paris, J., Campos, J., Wotherspoon, D., Durko, J., Sarapuu, A., Choe, J., et al. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20200829 · Cited by 142
“…which not only activate HSCs but also cause expansion of MPPs, in particular myeloid-biased MPP2/3 populations, thereby driving myeloid differentiation at the expense of HSC integrity (Essers et al., 2009; Pietras et al., 2016; Yamashita and Passegue, 2019; Zhang et al., 2017; Zhang et al., 2016).”
BackgroundMethodInfluentialMartelli, A. M., Evangelisti, C., Chiarini, F., Grimaldi, C., Cappellini, A., Ognibene, A., & McCubrey, J. A. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.04.005 · Cited by 152
“However, chronic INFα exposure, impaired HSC function in repopulation assays [83].”
BackgroundHaematopoietic stem cells in perisinusoidal niches are protected from ageing
Saçma, M., Pospiech, J., Bogeska, R., de Back, W., Mallm, J.-P., Sakk, V., Soller, K., Marka, G., Vollmer, A., Karns, R., et al. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0418-y · Cited by 133
Self-citationTang, D., Tao, S., Chen, Z., Koliesnik, I. O., Calmes, P. G., Hoerr, V., Han, B., Gebert, N., Zörnig, M., Löffler, B., et al. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20151100 · Cited by 133
“Consistent with a previous study (Essers et al., 2009), pIpC signifi cantly activated .”
Oncogenic Nras has bimodal effects on stem cells that sustainably increase competitiveness
Li, Q., Bohin, N., Wen, T., Ng, V., Magee, J., Chen, S.-C., Shannon, K., & Morrison, S. J. (2013) · Nature · doi:10.1038/nature12830 · Cited by 126
Type II Interferon Promotes Differentiation of Myeloid-Biased Hematopoietic Stem Cells
Matatall, K. A., Shen, C.-C., Challen, G. A., & King, K. Y. (2014) · Stem Cells · doi:10.1002/stem.1799 · Cited by 127
Interferon-alpha for the therapy of myeloproliferative neoplasms: targeting the malignant clone
Kiladjian, J., Giraudier, S., & Cassinat, B. (2015) · Leukemia · doi:10.1038/leu.2015.326 · Cited by 137
Clonal Hematopoiesis: Mechanisms Driving Dominance of Stem Cell Clones
Challen, G., & Goodell, M. A. (2020) · Blood · doi:10.1182/blood.2020006510 · Cited by 131
Agrawal, H., Jacob, N., Carreras, E., Bajaña, S., Putterman, C., Turner, S., Neas, B. R., Mathian, A., Koss, M. N., Stohl, W., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803872 · Cited by 130
“Recent reports showed that IFN- acting via IFNAR stimulates the proliferation of normally quiescent BM hematopoietic stem cells in vivo (51, 52).”
BackgroundClonal hematopoiesis: Mutation-specific adaptation to environmental change
Florez, M. A., Tran, B. T., Wathan, T. K., DeGregori, J., Pietras, E. M., & King, K. Y. (2022) · Cell Stem Cell · doi:10.1016/j.stem.2022.05.006 · Cited by 129
STING-associated lung disease in mice relies on T cells but not type I interferon
Luksch, H., Stinson, W. A., Platt, D. J., Qian, W., Kalugotla, G., Miner, C. A., Bennion, B. G., Gerbaulet, A., Rösen-Wolff, A., & Miner, J. J. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.01.044 · Cited by 127
Macrophages and Cardiovascular Health
Frodermann, V., & Nahrendorf, M. (2018) · Physiological Reviews · doi:10.1152/physrev.00068.2017 · Cited by 127
Neonatal Sepsis and Neutrophil Insufficiencies
Melvan, J. N., Bagby, G. J., Welsh, D. A., Nelson, S., & Zhang, P. (2010) · International Reviews of Immunology · doi:10.3109/08830181003792803 · Cited by 145
Scumpia, P. O., Kelly-Scumpia, K. M., Delano, M. J., Weinstein, J. S., Cuenca, A. G., Al-Quran, S., Bovio, I., Akira, S., Kumagai, Y., & Moldawer, L. L. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903652 · Cited by 129
Alveolar macrophages and type I IFN in airway homeostasis and immunity
Divangahi, M., King, I. L., & Pernet, E. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.03.005 · Cited by 142
MacNamara, K. C., Oduro, K., Martin, O., Jones, D. D., McLaughlin, M., Choi, K., Borjesson, D. L., & Winslow, G. M. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1001893 · Cited by 122
Hematopoietic stem cells through the ages: A lifetime of adaptation to organismal demands
Kasbekar, M., Mitchell, C. A., Proven, M. A., & Passegué, E. (2023) · Cell Stem Cell · doi:10.1016/j.stem.2023.09.013 · Cited by 132
RNA Splicing Modulation Selectively Impairs Leukemia Stem Cell Maintenance in Secondary Human AML
Crews, L. A., Balaian, L., Delos Santos, N. P., Leu, H. S., Court, A. C., Lazzari, E., Sadarangani, A., Zipeto, M. A., La Clair, J. J., Villa, R., et al. (2016) · Cell Stem Cell · doi:10.1016/j.stem.2016.08.003 · Cited by 121
“Age-related defects in hematopoietic stem cell (HSC) function (Essers et al., 2009) are typified by myeloid lineage bias (Pang et al., 2011) and altered survival, dormancy, and regenerative capacity.”
Heraud-Farlow, J. E., Chalk, A. M., Linder, S. E., Li, Q., Taylor, S., White, J. M., Pang, L., Liddicoat, B., Gupte, A., Li, J. B., et al. (2017) · Genome biology · doi:10.1186/s13059-017-1301-4 · Cited by 126
Zhang, H., Rodriguez, S., Wang, L., Wang, S., Serezani, H., Kapur, R., Cardoso, A. A., & Carlesso, N. (2016) · Stem Cell Reports · doi:10.1016/j.stemcr.2016.05.002 · Cited by 117
“LPS versus PBS: *p < 0.05, **p < 0.01; WT versus MYD88 / or (legend continued on next page) Stem Cell Reports j Vol. 6 j 940–956 j June 14, 2016 953 2014; Staber et al., 2013), revealed that they were significantly downregulated in WT HSPC following LPS treatment, while their levels were preserved in the absence of MY…”
BackgroundInfluentialClonal hematopoiesis driven by mutated DNMT3A promotes inflammatory bone loss
Wang, H., Divaris, K., Pan, B., Li, X., Lim, J., Saha, G., Barovic, M., Giannakou, D., Korostoff, J. M., Bing, Y., et al. (2024) · Cell · doi:10.1016/j.cell.2024.05.003 · Cited by 137
Side population and cancer stem cells: Therapeutic implications
Moserle, L., Ghisi, M., Amadori, A., & Indraccolo, S. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.05.020 · Cited by 135
Schoedel, K. B., Morcos, M. N. F., Zerjatke, T., Roeder, I., Grinenko, T., Voehringer, D., Göthert, J. R., Waskow, C., Roers, A., & Gerbaulet, A. (2016) · Blood · doi:10.1182/blood-2016-03-706010 · Cited by 120
Poscablo, D. M., Worthington, A. K., Smith‐Berdan, S., Rommel, M. G. E., Manso, B. A., Adili, R., Mok, L., Reggiardo, R. E., Cool, T., Mogharrab, R., et al. (2024) · Cell · doi:10.1016/j.cell.2024.04.018 · Cited by 129
Cell–cell interaction networks regulate blood stem and progenitor cell fate
Kirouac, D. C., Madlambayan, G. J., Yu, M., Sykes, E. A., Ito, C. Y., & Zandstra, P. W. (2009) · Molecular Systems Biology · doi:10.1038/msb.2009.49 · Cited by 135
“infection), circulating white blood cells can directly induce the proliferation of HSCs through the secretion of inflammatory cytokines”
BackgroundRegulation of the Bone Marrow Niche by Inflammation
Mitroulis, I., Kalafati, L., Bornhäuser, M., Hajishengallis, G., & Chavakis, T. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01540 · Cited by 125
Helbling, P. M., Piñeiro-Yáñez, E., Gerosa, R., Boettcher, S., Al-Shahrour, F., Manz, M. G., & Nombela-Arrieta, C. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.11.004 · Cited by 116
Improving outcomes in chronic myeloid leukemia through harnessing the immunological landscape
Hsieh, Y.-C., Kirschner, K., & Copland, M. (2021) · Leukemia · doi:10.1038/s41375-021-01238-w · Cited by 123
Inflammatory Pathophysiology as a Contributor to Myeloproliferative Neoplasms
Fisher, D. A. C., Fowles, J. S., Zhou, A., & Oh, S. T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.683401 · Cited by 115
Hasemann, M. S., Lauridsen, F. K. B., Waage, J., Jakobsen, J. S., Frank, A.-K., Schuster, M. B., Rapin, N., Bagger, F. O., Hoppe, P. S., Schroeder, T., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004079 · Cited by 103
“Indeed, it has previously been reported that interferons influence key HSC parameters such as proliferation, apoptosis and selfrenewal [40,41], and therefore, it is likely that the HSC compartment is affected differentially 4 and 14 days after”
BackgroundKim, J.-H., Thimmulappa, R. K., Kumar, V., Cui, W., Kumar, S., Kombairaju, P., Zhang, H., Margolick, J., Matsui, W., Macvittie, T., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci70812 · Cited by 110
Genetic Engineering of Hematopoiesis for Targeted IFN-α Delivery Inhibits Breast Cancer Progression
Escobar, G., Moi, D., Ranghetti, A., Ozkal-Baydin, P., Squadrito, M. L., Kajaste-Rudnitski, A., Bondanza, A., Gentner, B., De Palma, M., Mazzieri, R., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3006353 · Cited by 113
Metadata
- Authors
- Essers, M. A. G., Offner, S., Blanco-Bose, W. E., Waibler, Z., Kalinke, U., Duchosal, M. A., & Trumpp, A.
- Affiliations
- German Cancer Research Center (DE)
- École Polytechnique Fédérale de Lausanne (CH)
- Paul Ehrlich Institut (DE)
- Center for Experimental and Clinical Infection Research (DE)
- Centre Hospitalier Universitaire Vaudois (CH)
- Corresponding author
- Trumpp, Andreas
- Venue
- Nature
- Published
- 2009-02-11
- Volume
- 458
- Issue
- 7240
- Pages
- 904-908
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2011059916
- Cited by
- 1,368
- References
- 31
- Citations by year
- 2026: 59 · 2025: 72 · 2024: 67 · 2023: 96 · 2022: 91 · 2021: 99 · 2020: 90 · 2019: 72 · 2018: 68 · 2017: 81 · 2016: 82 · 2015: 60 · 2014: 99 · 2013: 80 · 2012: 71
- FWCI
- 56.02
- Type
- journal article
- Language
- en
- Open access
- green
- infoscience.epfl.ch
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Zenodo (CERN European Organization for Nuclear Research) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Keywords
- hematopoietic stem cells, interferon-alpha, HSC proliferation, STAT1, Sca-1, IFNAR, type I interferon, 5-fluorouracil, leukemia, cancer stem cells, chemosensitization
- MeSH terms
- Animals, Antigens, Ly, Cell Count, Cell Cycle, Fluorouracil, Hematopoietic Stem Cells, Membrane Proteins, Mice, Inbred C57BL, Phosphorylation, Signal Transduction, Up-Regulation, Interferon-alpha, Cell Proliferation, STAT1 Transcription Factor, Mice, Receptor, Interferon alpha-beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.